img

Global Oxycodone Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oxycodone Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Oxycodone market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oxycodone market research.
Key manufacturers engaged in the Oxycodone industry include Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Mallinckrodt and Mylan, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Oxycodone were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Oxycodone market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oxycodone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johnson & Johnson
Sanofi
Pfizer
Purdue Pharma
Endo International
Teva Pharmaceuticals
Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
Mallinckrodt
Mylan
Sun Pharmaceutical (Chattem Chemicals)
Impax Laboratories
Indivior
Segment by Type
Long Acting Oxycodone
Short Acting Oxycodone

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Oxycodone report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Oxycodone Market Overview
1.1 Product Overview and Scope of Oxycodone
1.2 Oxycodone Segment by Type
1.2.1 Global Oxycodone Market Value Comparison by Type (2024-2034)
1.2.2 Long Acting Oxycodone
1.2.3 Short Acting Oxycodone
1.3 Oxycodone Segment by Application
1.3.1 Global Oxycodone Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Global Oxycodone Market Size Estimates and Forecasts
1.4.1 Global Oxycodone Revenue 2018-2034
1.4.2 Global Oxycodone Sales 2018-2034
1.4.3 Global Oxycodone Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Oxycodone Market Competition by Manufacturers
2.1 Global Oxycodone Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oxycodone Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oxycodone Average Price by Manufacturers (2018-2023)
2.4 Global Oxycodone Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Oxycodone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxycodone, Product Type & Application
2.7 Oxycodone Market Competitive Situation and Trends
2.7.1 Oxycodone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oxycodone Players Market Share by Revenue
2.7.3 Global Oxycodone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oxycodone Retrospective Market Scenario by Region
3.1 Global Oxycodone Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Oxycodone Global Oxycodone Sales by Region: 2018-2034
3.2.1 Global Oxycodone Sales by Region: 2018-2023
3.2.2 Global Oxycodone Sales by Region: 2024-2034
3.3 Global Oxycodone Global Oxycodone Revenue by Region: 2018-2034
3.3.1 Global Oxycodone Revenue by Region: 2018-2023
3.3.2 Global Oxycodone Revenue by Region: 2024-2034
3.4 North America Oxycodone Market Facts & Figures by Country
3.4.1 North America Oxycodone Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Oxycodone Sales by Country (2018-2034)
3.4.3 North America Oxycodone Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oxycodone Market Facts & Figures by Country
3.5.1 Europe Oxycodone Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Oxycodone Sales by Country (2018-2034)
3.5.3 Europe Oxycodone Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxycodone Market Facts & Figures by Country
3.6.1 Asia Pacific Oxycodone Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Oxycodone Sales by Country (2018-2034)
3.6.3 Asia Pacific Oxycodone Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oxycodone Market Facts & Figures by Country
3.7.1 Latin America Oxycodone Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Oxycodone Sales by Country (2018-2034)
3.7.3 Latin America Oxycodone Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oxycodone Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxycodone Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Oxycodone Sales by Country (2018-2034)
3.8.3 Middle East and Africa Oxycodone Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oxycodone Sales by Type (2018-2034)
4.1.1 Global Oxycodone Sales by Type (2018-2023)
4.1.2 Global Oxycodone Sales by Type (2024-2034)
4.1.3 Global Oxycodone Sales Market Share by Type (2018-2034)
4.2 Global Oxycodone Revenue by Type (2018-2034)
4.2.1 Global Oxycodone Revenue by Type (2018-2023)
4.2.2 Global Oxycodone Revenue by Type (2024-2034)
4.2.3 Global Oxycodone Revenue Market Share by Type (2018-2034)
4.3 Global Oxycodone Price by Type (2018-2034)
5 Segment by Application
5.1 Global Oxycodone Sales by Application (2018-2034)
5.1.1 Global Oxycodone Sales by Application (2018-2023)
5.1.2 Global Oxycodone Sales by Application (2024-2034)
5.1.3 Global Oxycodone Sales Market Share by Application (2018-2034)
5.2 Global Oxycodone Revenue by Application (2018-2034)
5.2.1 Global Oxycodone Revenue by Application (2018-2023)
5.2.2 Global Oxycodone Revenue by Application (2024-2034)
5.2.3 Global Oxycodone Revenue Market Share by Application (2018-2034)
5.3 Global Oxycodone Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson & Johnson Oxycodone Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Oxycodone Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Oxycodone Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Purdue Pharma
6.4.1 Purdue Pharma Corporation Information
6.4.2 Purdue Pharma Description and Business Overview
6.4.3 Purdue Pharma Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Purdue Pharma Oxycodone Product Portfolio
6.4.5 Purdue Pharma Recent Developments/Updates
6.5 Endo International
6.5.1 Endo International Corporation Information
6.5.2 Endo International Description and Business Overview
6.5.3 Endo International Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Endo International Oxycodone Product Portfolio
6.5.5 Endo International Recent Developments/Updates
6.6 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Corporation Information
6.6.2 Teva Pharmaceuticals Description and Business Overview
6.6.3 Teva Pharmaceuticals Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Pharmaceuticals Oxycodone Product Portfolio
6.6.5 Teva Pharmaceuticals Recent Developments/Updates
6.7 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
6.6.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Corporation Information
6.6.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Description and Business Overview
6.6.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio
6.7.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Developments/Updates
6.8 Mallinckrodt
6.8.1 Mallinckrodt Corporation Information
6.8.2 Mallinckrodt Description and Business Overview
6.8.3 Mallinckrodt Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mallinckrodt Oxycodone Product Portfolio
6.8.5 Mallinckrodt Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mylan Oxycodone Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Sun Pharmaceutical (Chattem Chemicals)
6.10.1 Sun Pharmaceutical (Chattem Chemicals) Corporation Information
6.10.2 Sun Pharmaceutical (Chattem Chemicals) Description and Business Overview
6.10.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio
6.10.5 Sun Pharmaceutical (Chattem Chemicals) Recent Developments/Updates
6.11 Impax Laboratories
6.11.1 Impax Laboratories Corporation Information
6.11.2 Impax Laboratories Oxycodone Description and Business Overview
6.11.3 Impax Laboratories Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Impax Laboratories Oxycodone Product Portfolio
6.11.5 Impax Laboratories Recent Developments/Updates
6.12 Indivior
6.12.1 Indivior Corporation Information
6.12.2 Indivior Oxycodone Description and Business Overview
6.12.3 Indivior Oxycodone Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Indivior Oxycodone Product Portfolio
6.12.5 Indivior Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxycodone Industry Chain Analysis
7.2 Oxycodone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxycodone Production Mode & Process
7.4 Oxycodone Sales and Marketing
7.4.1 Oxycodone Sales Channels
7.4.2 Oxycodone Distributors
7.5 Oxycodone Customers
8 Oxycodone Market Dynamics
8.1 Oxycodone Industry Trends
8.2 Oxycodone Market Drivers
8.3 Oxycodone Market Challenges
8.4 Oxycodone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oxycodone Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Oxycodone Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Oxycodone Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oxycodone Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Oxycodone Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Oxycodone Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Oxycodone Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Oxycodone Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Oxycodone, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Oxycodone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oxycodone, Product Type & Application
Table 12. Global Key Manufacturers of Oxycodone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oxycodone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxycodone as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oxycodone Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Oxycodone Sales by Region (2018-2023) & (K Pcs)
Table 18. Global Oxycodone Sales Market Share by Region (2018-2023)
Table 19. Global Oxycodone Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Oxycodone Sales Market Share by Region (2024-2034)
Table 21. Global Oxycodone Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Oxycodone Revenue Market Share by Region (2018-2023)
Table 23. Global Oxycodone Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Oxycodone Revenue Market Share by Region (2024-2034)
Table 25. North America Oxycodone Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Oxycodone Sales by Country (2018-2023) & (K Pcs)
Table 27. North America Oxycodone Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Oxycodone Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Oxycodone Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Oxycodone Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Oxycodone Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe Oxycodone Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Oxycodone Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Oxycodone Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Oxycodone Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Oxycodone Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific Oxycodone Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Oxycodone Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Oxycodone Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Oxycodone Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Oxycodone Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America Oxycodone Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Oxycodone Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oxycodone Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Oxycodone Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Oxycodone Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa Oxycodone Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Oxycodone Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Oxycodone Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Oxycodone Sales (K Pcs) by Type (2018-2023)
Table 51. Global Oxycodone Sales (K Pcs) by Type (2024-2034)
Table 52. Global Oxycodone Sales Market Share by Type (2018-2023)
Table 53. Global Oxycodone Sales Market Share by Type (2024-2034)
Table 54. Global Oxycodone Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Oxycodone Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Oxycodone Revenue Market Share by Type (2018-2023)
Table 57. Global Oxycodone Revenue Market Share by Type (2024-2034)
Table 58. Global Oxycodone Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Oxycodone Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Oxycodone Sales (K Pcs) by Application (2018-2023)
Table 61. Global Oxycodone Sales (K Pcs) by Application (2024-2034)
Table 62. Global Oxycodone Sales Market Share by Application (2018-2023)
Table 63. Global Oxycodone Sales Market Share by Application (2024-2034)
Table 64. Global Oxycodone Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Oxycodone Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Oxycodone Revenue Market Share by Application (2018-2023)
Table 67. Global Oxycodone Revenue Market Share by Application (2024-2034)
Table 68. Global Oxycodone Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Oxycodone Price (USD/Pcs) by Application (2024-2034)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Johnson & Johnson Oxycodone Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. Sanofi Oxycodone Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Pfizer Oxycodone Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Purdue Pharma Corporation Information
Table 86. Purdue Pharma Description and Business Overview
Table 87. Purdue Pharma Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Purdue Pharma Oxycodone Product
Table 89. Purdue Pharma Recent Developments/Updates
Table 90. Endo International Corporation Information
Table 91. Endo International Description and Business Overview
Table 92. Endo International Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Endo International Oxycodone Product
Table 94. Endo International Recent Developments/Updates
Table 95. Teva Pharmaceuticals Corporation Information
Table 96. Teva Pharmaceuticals Description and Business Overview
Table 97. Teva Pharmaceuticals Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Teva Pharmaceuticals Oxycodone Product
Table 99. Teva Pharmaceuticals Recent Developments/Updates
Table 100. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Corporation Information
Table 101. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Description and Business Overview
Table 102. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product
Table 104. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Developments/Updates
Table 105. Mallinckrodt Corporation Information
Table 106. Mallinckrodt Description and Business Overview
Table 107. Mallinckrodt Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Mallinckrodt Oxycodone Product
Table 109. Mallinckrodt Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. Mylan Oxycodone Product
Table 114. Mylan Recent Developments/Updates
Table 115. Sun Pharmaceutical (Chattem Chemicals) Corporation Information
Table 116. Sun Pharmaceutical (Chattem Chemicals) Description and Business Overview
Table 117. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product
Table 119. Sun Pharmaceutical (Chattem Chemicals) Recent Developments/Updates
Table 120. Impax Laboratories Corporation Information
Table 121. Impax Laboratories Description and Business Overview
Table 122. Impax Laboratories Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Impax Laboratories Oxycodone Product
Table 124. Impax Laboratories Recent Developments/Updates
Table 125. Indivior Corporation Information
Table 126. Indivior Description and Business Overview
Table 127. Indivior Oxycodone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Indivior Oxycodone Product
Table 129. Indivior Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Oxycodone Distributors List
Table 133. Oxycodone Customers List
Table 134. Oxycodone Market Trends
Table 135. Oxycodone Market Drivers
Table 136. Oxycodone Market Challenges
Table 137. Oxycodone Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oxycodone
Figure 2. Global Oxycodone Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Oxycodone Market Share by Type in 2024 & 2034
Figure 4. Long Acting Oxycodone Product Picture
Figure 5. Short Acting Oxycodone Product Picture
Figure 6. Global Oxycodone Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Oxycodone Market Share by Application in 2024 & 2034
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Others
Figure 11. Global Oxycodone Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Oxycodone Market Size (2018-2034) & (US$ Million)
Figure 13. Global Oxycodone Sales (2018-2034) & (K Pcs)
Figure 14. Global Oxycodone Average Price (USD/Pcs) & (2018-2034)
Figure 15. Oxycodone Report Years Considered
Figure 16. Oxycodone Sales Share by Manufacturers in 2024
Figure 17. Global Oxycodone Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Oxycodone Players: Market Share by Revenue in 2024
Figure 19. Oxycodone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Oxycodone Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Oxycodone Sales Market Share by Country (2018-2034)
Figure 22. North America Oxycodone Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Oxycodone Sales Market Share by Country (2018-2034)
Figure 26. Europe Oxycodone Revenue Market Share by Country (2018-2034)
Figure 27. Germany Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Oxycodone Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Oxycodone Revenue Market Share by Region (2018-2034)
Figure 34. China Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Oxycodone Sales Market Share by Country (2018-2034)
Figure 45. Latin America Oxycodone Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Oxycodone Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Oxycodone Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. U.A.E Oxycodone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Oxycodone by Type (2018-2034)
Figure 55. Global Revenue Market Share of Oxycodone by Type (2018-2034)
Figure 56. Global Oxycodone Price (USD/Pcs) by Type (2018-2034)
Figure 57. Global Sales Market Share of Oxycodone by Application (2018-2034)
Figure 58. Global Revenue Market Share of Oxycodone by Application (2018-2034)
Figure 59. Global Oxycodone Price (USD/Pcs) by Application (2018-2034)
Figure 60. Oxycodone Value Chain
Figure 61. Oxycodone Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed